The Global Oxomemazine (CAS 3689-50-7) Market was valued at USD 65.8 Million in 2023 and is projected to reach USD 89.2 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period (2023–2030). This expansion reflects rising therapeutic demand for antihistamine formulations and increasing R&D investments in sedative medications worldwide.

Oxomemazine remains a clinically significant phenothiazine derivative with established efficacy in allergy management and stress-related conditions. As pharmaceutical innovation accelerates, industry leaders are enhancing production processes and expanding distribution networks. This report examines the Top 10 Companies in the Oxomemazine Market—key manufacturers driving formulation advancements and supply chain reliability.

---

🔟 1. Alfa Chemistry

Headquarters: New York, USA
Key Offering: Research-grade Oxomemazine and custom synthesis solutions

Alfa Chemistry maintains industry leadership through its specialized production of high-purity Oxomemazine for pharmaceutical research. The company’s technical expertise supports drug discovery programs and clinical trial material production across North America and Europe.

Technical Capabilities:

• Purity levels exceeding 99.5%
• Multi-kilogram production capacity
• Regulatory support for IND/NDA submissions

Download FREE Sample Report:
Oxomemazine (CAS 3689-50-7) Market – View in Detailed Research Report

---

9️⃣ 2. AlliChem

Headquarters: Virginia, USA
Key Offering: GMP-compliant Oxomemazine API

AlliChem provides pharmaceutical manufacturers with certified active ingredients meeting international pharmacopeia standards. Their Oxomemazine production integrates advanced purification technologies for enhanced therapeutic consistency.

Technical Capabilities:

• ICH stability protocol compliance
• Controlled substance handling expertise
• Strict impurity profile control

---

8️⃣ 3. Waterstone Technology

Headquarters: Indiana, USA
Key Offering: Oxomemazine analytical standards and metabolites

Waterstone Technology delivers critical quality control materials for Oxomemazine product development and manufacturing. Their reference materials enable precise method validation and regulatory compliance.

Technical Capabilities:

• USP/EP reference standards
• Stability-indicating methods
• Impurity isolation services

---

7️⃣ 4. 3B Scientific

Headquarters: Hamburg, Germany
Key Offering: Oxomemazine for pharmacological studies

3B Scientific supplies research institutions with pharmaceutical compounds for preclinical evaluation. Their Oxomemazine products support neurological and immunological research applications.

Technical Capabilities:

• Multiple salt form availability
• Custom Radiolabeling services
• GLP-compliant documentation

Download FREE Sample Report:
Oxomemazine (CAS 3689-50-7) Market – View in Detailed Research Report

---

6️⃣ 5. ShangHai AmK Pharmaceutical Technology

Headquarters: Shanghai, China
Key Offering: Cost-competitive Oxomemazine API

ShangHai AmK operates one of Asia’s largest production facilities for antihistamine APIs. Their Oxomemazine manufacturing process combines traditional synthesis with modern purification techniques.

Technical Capabilities:

• 500kg+ monthly production capacity
• DMF filings in multiple regions
• Process validation support

---

5️⃣ 6. Shanghai New Union Textra

Headquarters: Shanghai, China
Key Offering: Oxomemazine intermediates and finished API

Shanghai New Union Textra provides comprehensive solutions from chemical synthesis to finished API production. Their vertically integrated operations ensure quality control throughout manufacturing stages.

Technical Capabilities:

• Continuous manufacturing capabilities
• QbD approach implementation
• Patent-protected synthesis routes

---

4️⃣ 7. Yick-Vic Chemicals & Pharmaceuticals

Headquarters: Hong Kong
Key Offering: Novel Oxomemazine formulations

Yick-Vic focuses on developing enhanced-delivery formulations of Oxomemazine to improve therapeutic outcomes. Their portfolio includes controlled-release and specialty dosage forms.

Technical Capabilities:

• Modified-release technologies
• Formulation patent portfolio
• Bioavailability enhancement expertise

---

3️⃣ 8. Hangzhou Hyper Chemicals

Headquarters: Zhejiang, China
Key Offering: Oxomemazine manufacturing intermediates

Hangzhou Hyper Chemicals specializes in key starting materials for antihistamine production. Their intermediates enable efficient scaling of Oxomemazine synthesis processes.

Technical Capabilities:

• Cost-effective precursor chemicals
• Custom synthesis routes
• Strict impurity controls

---

2️⃣ 9. Caming Pharmaceutical

Headquarters: Nanjing, China
Key Offering: Complete Oxomemazine API solutions

Caming Pharmaceutical offers end-to-end support from process development to commercial manufacturing. Their Oxomemazine products serve global generic and branded pharmaceutical markets.

Technical Capabilities:

• Regulatory submission support
• Scale-up expertise
• Environmental sustainability initiatives

---

1️⃣ 10. Career Henan Chemical

Headquarters: Henan, China
Key Offering: Oxomemazine API and research compounds

Career Henan completes our ranking with its focused chemical synthesis capabilities. The company provides reliable supply chain solutions to pharmaceutical manufacturers worldwide.

Technical Capabilities:

• Rapid production scale-up
• Global export network
• Technical transfer support

Get Full Report Here:
Oxomemazine (CAS 3689-50-7) Market – View in Detailed Research Report

---

💊 Market Outlook: Innovation Trends in Oxomemazine Development

The Oxomemazine market is witnessing transformative changes as manufacturers optimize formulations and production processes. Emerging therapeutic applications and regulatory requirements continue to shape industry dynamics.

🔬 Emerging Industry Developments:

• Advancements in extended-release formulations
• Increasing pediatric formulation research
• Process intensification in API manufacturing
• Growing quality control requirements

Get Full Report Here:
Oxomemazine (CAS 3689-50-7) Market – View in Detailed Research Report

The profiled companies represent the vanguard of pharmaceutical innovation, combining scientific expertise with manufacturing excellence to advance antihistamine therapies.